VIRAZOLE
Google image searchProduct monograph
Active ingredient
ribavirin, 6 G/VIAL
DIN: 02170140
Dosage form(s): AEROSOL, POWDER FOR SOLUTION
Route(s) of administration: INHALATION
Schedule: Prescription
Company: BAUSCH HEALTH, CANADA INC.
Date: 30-SEP-2020
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AP — Antivirals for treatment of HCV infections (ATC, ATC/DDD)
- J05AP01 — RIBAVIRIN (ATC/DDD)
Reference brand drug: Virazole
Pharmaceutical standard: USP
